Exponent Inc EXPO
We take great care to ensure that the data presented and summarized in this overview for EXPONENT INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding EXPO
View all-
Black Rock Inc. New York, NY5.99MShares$591 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.28MShares$521 Million0.01% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA4.78MShares$471 Million1.26% of portfolio
-
Conestoga Capital Advisors, LLC2.81MShares$277 Million4.48% of portfolio
-
Neuberger Berman Group LLC New York, NY2.39MShares$236 Million0.22% of portfolio
-
State Street Corp Boston, MA1.84MShares$182 Million0.01% of portfolio
-
Geneva Capital Management LLC1.59MShares$157 Million3.12% of portfolio
-
Geode Capital Management, LLC Boston, MA1.51MShares$149 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.18MShares$116 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX974KShares$96.1 Million0.03% of portfolio
Latest Institutional Activity in EXPO
Top Purchases
Top Sells
About EXPO
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Insider Transactions at EXPO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 20
2024
|
Paul R Johnston Director |
SELL
Open market or private sale
|
Direct |
1,300
-2.14%
|
$123,500
$95.03 P/Share
|
Nov 20
2024
|
Paul R Johnston Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+2.1%
|
$48,100
$37.45 P/Share
|
Nov 20
2024
|
Richard L Schlenker Jr EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
10,000
-4.46%
|
-
|
Nov 15
2024
|
Paul R Johnston Director |
SELL
Open market or private sale
|
Direct |
7,000
-10.54%
|
$686,000
$98.32 P/Share
|
Nov 15
2024
|
Paul R Johnston Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+9.54%
|
$259,000
$37.45 P/Share
|
Nov 13
2024
|
Paul R Johnston Director |
SELL
Bona fide gift
|
Direct |
21,336
-26.42%
|
-
|
Nov 12
2024
|
Paul R Johnston Director |
SELL
Open market or private sale
|
Direct |
7,000
-7.98%
|
$721,000
$103.83 P/Share
|
Nov 12
2024
|
Paul R Johnston Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+7.39%
|
$259,000
$37.45 P/Share
|
Nov 08
2024
|
Catherine Corrigan President & CEO |
SELL
Bona fide gift
|
Direct |
2,842
-3.57%
|
-
|
Nov 07
2024
|
Paul R Johnston Director |
SELL
Open market or private sale
|
Direct |
7,000
-7.98%
|
$721,000
$103.65 P/Share
|
Nov 07
2024
|
Paul R Johnston Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+7.39%
|
$259,000
$37.45 P/Share
|
Nov 06
2024
|
Paul R Johnston Director |
SELL
Open market or private sale
|
Direct |
14,000
-7.75%
|
$1,456,000
$104.6 P/Share
|
Nov 06
2024
|
Paul R Johnston Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+7.03%
|
$518,000
$37.45 P/Share
|
Nov 04
2024
|
Carol Lindstrom Director |
SELL
Open market or private sale
|
Direct |
1,039
-15.04%
|
$99,744
$96.32 P/Share
|
Aug 21
2024
|
Debra Zumwalt Director |
SELL
Bona fide gift
|
Direct |
313
-1.09%
|
$32,552
$104.1 P/Share
|
Jul 31
2024
|
Richard L Schlenker Jr EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40,662
-5.49%
|
$4,310,172
$106.72 P/Share
|
Jul 31
2024
|
Richard L Schlenker Jr EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,558
+10.16%
|
$828,182
$29.05 P/Share
|
Jul 31
2024
|
Richard Reiss Group Vice President |
SELL
Open market or private sale
|
Direct |
2,206
-38.42%
|
$236,042
$107.46 P/Share
|
Jul 30
2024
|
Richard L Schlenker Jr EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
57,652
-19.62%
|
$6,168,764
$107.17 P/Share
|
Jul 30
2024
|
John Pye Group Vice President |
SELL
Open market or private sale
|
Direct |
3,956
-12.22%
|
$415,380
$105.0 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 178K shares |
---|
Bona fide gift | 34.5K shares |
---|---|
Payment of exercise price or tax liability | 22K shares |
Open market or private sale | 211K shares |